En español
NIDA

Menu

Cocaine Use Reduction with Buprenorphine (CURB)

The aim of this study is to investigate the safety and effectiveness of buprenorphine in the presence of naltrexone for the treatment of cocaine dependence in a sample of individuals meeting diagnostic criteria for both cocaine and opioid dependence or opioid abuse.

CTN Protocol ID: 
CTN-0048
Enrollment Status: 
Completed
ClinicalTrials.gov ID: 
Principal Investigator(s)
Walter Ling, M.D.
Director
Integrated Substance Abuse Programs
University of California, Los Angeles
11075 Santa Monica Boulevard
Suite 200
Los Angeles, CA 90025
lwalter@ucla.edu

Get this Publication

    Blending Initiative

    blending logo

    Formed with SAMHSA to reduce the gap between research results and treatment.